Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology

ABSTRACT: This study uses proteome microarray technology/data to identify predictive biomarkers of neutralizing antibody response and potential new correlates of protective immunity in rubella virus serology.

ORGANISM(S): Homo sapiens Rubella virus vaccine strain RA27/3

PROVIDER: GSE104148 | GEO | 2017/09/23

SECONDARY ACCESSION(S): PRJNA411822

REPOSITORIES: GEO